Nothing Special   »   [go: up one dir, main page]

IT1264690B1 - Compositi oligomeri iodurati e composizioni diagnostiche contenenti gli stessi - Google Patents

Compositi oligomeri iodurati e composizioni diagnostiche contenenti gli stessi

Info

Publication number
IT1264690B1
IT1264690B1 IT93MI001479A ITMI931479A IT1264690B1 IT 1264690 B1 IT1264690 B1 IT 1264690B1 IT 93MI001479 A IT93MI001479 A IT 93MI001479A IT MI931479 A ITMI931479 A IT MI931479A IT 1264690 B1 IT1264690 B1 IT 1264690B1
Authority
IT
Italy
Prior art keywords
iodurated
same
compositions containing
diagnostic compositions
composites
Prior art date
Application number
IT93MI001479A
Other languages
English (en)
Inventor
Pier Lucio Anelli
Marino Brocchetta
Haen Christoph De
Ornella Gazzotti
Fulvio Uggeri
Sandra Verona
Massimo Visigalli
Original Assignee
Bracco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Spa filed Critical Bracco Spa
Publication of ITMI931479A0 publication Critical patent/ITMI931479A0/it
Priority to IT93MI001479A priority Critical patent/IT1264690B1/it
Priority to AU71251/94A priority patent/AU7125194A/en
Priority to JP7503801A priority patent/JPH08512297A/ja
Priority to EP94920471A priority patent/EP0707572A1/en
Priority to PCT/EP1994/002111 priority patent/WO1995001966A1/en
Priority to IL11024994A priority patent/IL110249A0/xx
Priority to IS4189A priority patent/IS4189A/is
Priority to ZA944923A priority patent/ZA944923B/xx
Publication of ITMI931479A1 publication Critical patent/ITMI931479A1/it
Application granted granted Critical
Publication of IT1264690B1 publication Critical patent/IT1264690B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/50—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0442—Polymeric X-ray contrast-enhancing agent comprising a halogenated group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invenzione si riferisce ad agenti di contrasto particolarmente utili per l'indagine diagnostica roentgenografica del distretto vascolare del corpo umano ed animale.
IT93MI001479A 1993-07-08 1993-07-08 Compositi oligomeri iodurati e composizioni diagnostiche contenenti gli stessi IT1264690B1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT93MI001479A IT1264690B1 (it) 1993-07-08 1993-07-08 Compositi oligomeri iodurati e composizioni diagnostiche contenenti gli stessi
PCT/EP1994/002111 WO1995001966A1 (en) 1993-07-08 1994-06-29 Iodinated oligomeric compounds and diagnostic compositions containing the same
JP7503801A JPH08512297A (ja) 1993-07-08 1994-06-29 ヨウ素化オリゴマー化合物およびこれを含む診断用組成物
EP94920471A EP0707572A1 (en) 1993-07-08 1994-06-29 Iodinated oligomeric compounds and diagnostic compositions containing the same
AU71251/94A AU7125194A (en) 1993-07-08 1994-06-29 Iodinated oligomeric compounds and diagnostic compositions containing the same
IL11024994A IL110249A0 (en) 1993-07-08 1994-07-07 Iodinated oligomeric compounds and diagnostic compositions containing the same
IS4189A IS4189A (is) 1993-07-08 1994-07-07 Joðuð fáliða efnasambönd og efnasambönd til greiningar sem innihalda þau
ZA944923A ZA944923B (en) 1993-07-08 1994-07-07 Iodinated oligomeric compounds and diagnostic compositions containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93MI001479A IT1264690B1 (it) 1993-07-08 1993-07-08 Compositi oligomeri iodurati e composizioni diagnostiche contenenti gli stessi

Publications (3)

Publication Number Publication Date
ITMI931479A0 ITMI931479A0 (it) 1993-07-08
ITMI931479A1 ITMI931479A1 (it) 1995-01-08
IT1264690B1 true IT1264690B1 (it) 1996-10-04

Family

ID=11366554

Family Applications (1)

Application Number Title Priority Date Filing Date
IT93MI001479A IT1264690B1 (it) 1993-07-08 1993-07-08 Compositi oligomeri iodurati e composizioni diagnostiche contenenti gli stessi

Country Status (8)

Country Link
EP (1) EP0707572A1 (it)
JP (1) JPH08512297A (it)
AU (1) AU7125194A (it)
IL (1) IL110249A0 (it)
IS (1) IS4189A (it)
IT (1) IT1264690B1 (it)
WO (1) WO1995001966A1 (it)
ZA (1) ZA944923B (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2200495A1 (en) * 1994-09-22 1996-03-28 Guerbet S.A. Polyiodo compounds, their preparation and their use in x-ray radiology
PL314490A1 (en) * 1994-09-22 1996-09-16 Guerbet Sa Iodinated derivatives, method of obtaining and using them as contrasting agents in x-raying
IT1271134B (it) * 1994-12-01 1997-05-26 Bracco Spa Derivati iodurati del bifenile e loro impiego diagnostico
DE19740403C2 (de) * 1997-09-09 1999-11-11 Schering Ag Neue Kontrastmittel
EP1549322B1 (en) * 2002-05-09 2010-02-17 Oncothyreon Inc. Lipid a and other carbohydrate ligand analogs
NO20055702D0 (no) 2005-12-02 2005-12-02 Amersham Health As Contrast agents
EP1986993B1 (en) * 2006-02-14 2012-12-05 Ge Healthcare As Contrast agents
US8067637B2 (en) 2006-02-14 2011-11-29 Ge Healthcare As Contrast agents
WO2007094683A1 (en) 2006-02-15 2007-08-23 Ge Healthcare As Contrast agents
EP2021317A1 (en) * 2006-05-11 2009-02-11 GE Healthcare AS Contrast agents
US8066974B2 (en) 2006-05-11 2011-11-29 Ge Healthcare As Contrast agents
US7662859B2 (en) 2007-02-16 2010-02-16 Ge Healthcare As Contrast agents
WO2008123779A1 (en) * 2007-04-04 2008-10-16 Ge Healthcare As Trisubstituted triazamacrocycli c compounds and their use as contrast agents
NO20073382L (no) * 2007-06-29 2008-12-30 Ge Healthcare As Contrast Agents
US8202511B2 (en) 2007-10-12 2012-06-19 Ge Healthcare As Contrast agents
CN103781469B (zh) 2011-02-24 2015-09-16 肿瘤防护公司 含有佐剂的以muc1为基础的糖脂肽疫苗
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
US10975060B2 (en) 2016-11-28 2021-04-13 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
CN106928087B (zh) * 2017-03-13 2019-01-22 牡丹江医学院 一种ct胃肠道造影剂及其应用
PE20211471A1 (es) 2018-11-23 2021-08-05 Bayer Ag Formulacion de medios de contraste y proceso para prepararlos
EP4015509A1 (en) * 2020-12-18 2022-06-22 Justesa Imagen S.A.U Organometallic compounds and their use as multimodal contrasting media for imaging diagnosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065553A (en) * 1974-05-31 1977-12-27 Laboratoires Andre Guerbet X-Ray contrast media
GB1491129A (en) * 1975-06-04 1977-11-09 Guerbet Sa Iodo-benzene derivatives and an x-ray contrast medium containing them
US5162109A (en) * 1990-09-13 1992-11-10 Mallinckrodt Medical, Inc. Magnetic resonance imaging agents
US5019371A (en) * 1990-11-21 1991-05-28 Mallinckrodt Medical, Inc. Novel x-ray contrast agents, compositions and methods

Also Published As

Publication number Publication date
JPH08512297A (ja) 1996-12-24
IS4189A (is) 1995-01-09
WO1995001966A1 (en) 1995-01-19
IL110249A0 (en) 1994-10-21
ITMI931479A0 (it) 1993-07-08
EP0707572A1 (en) 1996-04-24
ITMI931479A1 (it) 1995-01-08
AU7125194A (en) 1995-02-06
ZA944923B (en) 1995-03-14

Similar Documents

Publication Publication Date Title
IT1264690B1 (it) Compositi oligomeri iodurati e composizioni diagnostiche contenenti gli stessi
BG103438A (en) Improvements of or in relation to diagnostic/therapeutical forms
BR9607260A (pt) Utilização de aerogéis em agricultura
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
ATE337019T1 (de) Geladene lipide und deren verwendung
TW347335B (en) Solid silicone compositions and methods for their preparation and use
ZA943744B (en) Therapeutic substituted guanidines
HK1025737A1 (en) Treatment of multiple sclerosis through ingestion of copolymer-1
DK486189D0 (da) Psyllium-froeskaller og midler omfattende samme
EP0856315A4 (en) DRUG
UA26973A1 (uk) Засіб для профілактики судиhhих захворюваhь, які обумовлеhі дією глікопротеїhзв'язаhих пероксидів
IT9067434A0 (it) Procedimento per migliorare l'efficacia terapeutica di corticosteroidi liposolubili e composizione per l'attuazione di tale procedimento
PL309386A1 (en) Ortho-amino-substituted benzoyl guanidines, method of obtaining them their application as therapeutric or diagnostic agents and therapeutic agent containing them
ES8607217A1 (es) Un procedimiento para la preparacion de (r)-4-amino-n-(1-fe-niletil)benzamida,(s)-4-amino-n-(1-feniletil)benzamida,o unasal de las mismas
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
ATE195055T1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
SI0828483T1 (en) Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase
ITBO940254A0 (it) Metodo per il miglioramento di alcune funzionalita' del corpo umano.
IT1273509B (it) Composti azolici ad attivita' antimicotica per uso umano e veterinario
UA10825A (uk) Протимікробhий засіб
ITMI931328A0 (it) Apparecchiatura per l'applicazione al corpo umano di correnti continue e/o variabili per ionoforesi o per elettrostimolazione
UA19504A (uk) Засіб для лікуваhhя гhійhих запалеhь шкіри та підшкірhої клітковиhи
IT1280261B1 (it) Procedimento per la sterilizzazione e l'aerazione del terreno e apparecchiatura per attuare tale procedimento.
ITMI942076A0 (it) Procedimento per la riduzione del contenuto di nicotina mediante l'azione di microrganismi
IT8719336A0 (it) Composizione per l'occlusione di dotti e cavita' nell'organismo.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970729